Wells Fargo & Company MN lowered its stake in shares of SPDR S&P Biotech (NYSEARCA:XBI) by 3.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,410,917 shares of the exchange traded fund’s stock after selling 55,085 shares during the period. Wells Fargo & Company MN’s holdings in SPDR S&P Biotech were worth $108,894,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the company. Ballentine Partners LLC acquired a new position in shares of SPDR S&P Biotech during the 2nd quarter worth approximately $121,000. National Planning Corp acquired a new position in shares of SPDR S&P Biotech during the 2nd quarter worth approximately $211,000. Boston Advisors LLC acquired a new position in shares of SPDR S&P Biotech during the 2nd quarter worth approximately $213,000. Blair William & Co. IL acquired a new position in shares of SPDR S&P Biotech during the 2nd quarter worth approximately $227,000. Finally, Telemus Capital LLC acquired a new position in shares of SPDR S&P Biotech during the 2nd quarter worth approximately $232,000.

TRADEMARK VIOLATION WARNING: “Wells Fargo & Company MN Has $108.89 Million Stake in SPDR S&P Biotech (XBI)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.thecerbatgem.com/2017/09/12/wells-fargo-company-mn-has-108-89-million-stake-in-spdr-sp-biotech-xbi.html.

SPDR S&P Biotech (NYSEARCA XBI) opened at 83.88 on Tuesday. SPDR S&P Biotech has a 12-month low of $53.15 and a 12-month high of $84.90. The company’s 50 day moving average price is $78.98 and its 200-day moving average price is $73.57.

SPDR S&P Biotech Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Stock Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related stocks with our FREE daily email newsletter.